Published June 7, 2018 | Version v1
Patent Open

NANOPARTICLES FOR PHOTODYNAMIC THERAPY, X-RAY INDUCED PHOTODYNAMIC THERAPY, RADIOTHERAPY, RADIODYNAMIC THERAPY, CHEMOTHERAPY, IMMUNOTHERAPY, AND ANY COMBINATION THEREOF

Description

Metal-organic frameworks (MOFs) comprising photosensitizers are described. The MOFs can also include moieties capable of absorbing X-rays or other ionizing irradiation energy and/or scintillation. Optionally, the photosensitizer or a derivative thereof can form a bridging ligand of the MOF. Further optionally, the MOF can comprise inorganic nanoparticles in the cavities or channels of the MOF or can be used in combination with an inorganic nanoparticle. Also described are methods of using MOFs and/or inorganic nanoparticles in photodynamic therapy, X-ray induced photodynamic therapy, radiotherapy, radiodynamic therapy, or in radiotherapy-radiodynamic therapy, either with or without the co-administration of one or more immunotherapeutic agent and/or one or more chemotherapeutic agent.

Files

US20180153796.pdf

Files (4.6 MB)

Name Size Download all
md5:561c29675013d2a6c56637ad2ecea4ad
4.6 MB Preview Download

Additional details

Identifiers

Patent application number
US 201815884036 A
Patent number
US 2018/0153796 A1
Other
oai:uchicago.tind.io:7933

Dates

Patent filed
2018-01-30

UChicago Information

Division(s)
Physical Sciences Division
Department(s)
Chemistry